Bella Pharmaceuticals Recalls Lidocaine Ophthalmic Gel Due to Sterility Concerns
Bella Pharmaceuticals is recalling Lidocaine Ophthalmic Gel 3.5% because the product lacks assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an ophthalmic product, which poses a significant risk of infection and potential serious injury.
Plain-English summary
Bella Pharmaceuticals, Inc. is recalling Lidocaine Ophthalmic Gel 3.5%, 15mL bottles, prescription only. The recall is due to a lack of assurance of sterility.
The affected product is identified by Lot # BPLG3508717 with an expiration date of 11/7/17. A total of 6 bottles were involved in this recall. The product was distributed nationwide within the USA.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- Lidocaine Ophthalmic Gel 3.5%, 15mL bottles, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659,1(877) BELLA.
- Manufacturer
- Bella Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Affected units
- 6
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: BPLG3508717
- Exp. 11/7/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Bella Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Bella Pharmaceuticals, Inc.
See all →- SevereBella Pharmaceuticals Recalls Mannitol 20% Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls Fluorescein Sodium Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls L-Glutamine Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls PF-Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29